More harmonisation in EU clinical trials on the cards
This article was originally published in Scrip
An assessment of the European Clinical Trials Directive could lead to greater harmonisation among member states, said Dr Martin Terberger, head of the pharmaceutical unit in the European Commission's enterprise and industry directorate general, speaking at the DIA Euro meeting in Berlin this week.
You may also be interested in...
Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
The European Medicines Agency received more requests for scientific advice in 2019 than it did in 2018. Meanwhile, requests for advice in other areas has fallen.